Description: - A unique collection of 2080 HIF-1 related small chemicals can be used for drug discovery in ischemic disease and cancer and related mechanism studies;- Covers PI3K-AKT, MAPK, Ubiquitination signaling pathways and targets such as HIF, HIF Prolyl-Hydroxylase, E1/E2/E3 Enzyme, PI3K, MAPK, Proteasome, etc.- Part of them are in clinical trial phase or FDA approved;- Detailed compound information with structure, target, and biological activity description;- NMR and HPLC validated to ensure high purity and quality.